Cargando…

Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity

BACKGROUND: Respiratory syncytial virus (RSV) is the number one cause of lower respiratory tract infections in infants. There are still no vaccines or specific antiviral therapies against RSV, mainly due to the inadequate understanding of RSV pathogenesis. Recent data suggest a role for gut microbio...

Descripción completa

Detalles Bibliográficos
Autores principales: Harding, Jeffrey N., Siefker, David, Vu, Luan, You, Dahui, DeVincenzo, John, Pierre, JF., Cormier, Stephania A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268675/
https://www.ncbi.nlm.nih.gov/pubmed/32487019
http://dx.doi.org/10.1186/s12866-020-01816-5
_version_ 1783541669197512704
author Harding, Jeffrey N.
Siefker, David
Vu, Luan
You, Dahui
DeVincenzo, John
Pierre, JF.
Cormier, Stephania A.
author_facet Harding, Jeffrey N.
Siefker, David
Vu, Luan
You, Dahui
DeVincenzo, John
Pierre, JF.
Cormier, Stephania A.
author_sort Harding, Jeffrey N.
collection PubMed
description BACKGROUND: Respiratory syncytial virus (RSV) is the number one cause of lower respiratory tract infections in infants. There are still no vaccines or specific antiviral therapies against RSV, mainly due to the inadequate understanding of RSV pathogenesis. Recent data suggest a role for gut microbiota community structure in determining RSV disease severity. Our objective was to determine the gut microbial profile associated with severe RSV patients, which could be used to help identify at-risk patients and develop therapeutically protective microbial assemblages that may stimulate immuno-protection. RESULTS: We enrolled 95 infants from Le Bonheur during the 2014 to 2016 RSV season. Of these, 37 were well-babies and 58 were hospitalized with RSV. Of the RSV infected babies, 53 remained in the pediatric ward (moderate) and 5 were moved to the pediatric intensive care unit at a later date (severe). Stool samples were collected within 72 h of admission; and the composition of gut microbiota was evaluated via 16S sequencing of fecal DNA. There was a significant enrichment in S24_7, Clostridiales, Odoribacteraceae, Lactobacillaceae, and Actinomyces in RSV (moderate and severe) vs. controls. Patients with severe RSV disease had slightly lower alpha diversity (richness and evenness of the bacterial community) of the gut microbiota compared to patients with moderate RSV and healthy controls. Beta diversity (overall microbial composition) was significantly different between all RSV patients (moderate and severe) compared to controls and had significant microbial composition separating all three groups (control, moderate RSV, and severe RSV). CONCLUSIONS: Collectively, these data demonstrate that a unique gut microbial profile is associated with RSV disease and with severe RSV disease with admission to the pediatric intensive care unit. More mechanistic experiments are needed to determine whether the differences observed in gut microbiota are the cause or consequences of severe RSV disease.
format Online
Article
Text
id pubmed-7268675
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72686752020-06-08 Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity Harding, Jeffrey N. Siefker, David Vu, Luan You, Dahui DeVincenzo, John Pierre, JF. Cormier, Stephania A. BMC Microbiol Research Article BACKGROUND: Respiratory syncytial virus (RSV) is the number one cause of lower respiratory tract infections in infants. There are still no vaccines or specific antiviral therapies against RSV, mainly due to the inadequate understanding of RSV pathogenesis. Recent data suggest a role for gut microbiota community structure in determining RSV disease severity. Our objective was to determine the gut microbial profile associated with severe RSV patients, which could be used to help identify at-risk patients and develop therapeutically protective microbial assemblages that may stimulate immuno-protection. RESULTS: We enrolled 95 infants from Le Bonheur during the 2014 to 2016 RSV season. Of these, 37 were well-babies and 58 were hospitalized with RSV. Of the RSV infected babies, 53 remained in the pediatric ward (moderate) and 5 were moved to the pediatric intensive care unit at a later date (severe). Stool samples were collected within 72 h of admission; and the composition of gut microbiota was evaluated via 16S sequencing of fecal DNA. There was a significant enrichment in S24_7, Clostridiales, Odoribacteraceae, Lactobacillaceae, and Actinomyces in RSV (moderate and severe) vs. controls. Patients with severe RSV disease had slightly lower alpha diversity (richness and evenness of the bacterial community) of the gut microbiota compared to patients with moderate RSV and healthy controls. Beta diversity (overall microbial composition) was significantly different between all RSV patients (moderate and severe) compared to controls and had significant microbial composition separating all three groups (control, moderate RSV, and severe RSV). CONCLUSIONS: Collectively, these data demonstrate that a unique gut microbial profile is associated with RSV disease and with severe RSV disease with admission to the pediatric intensive care unit. More mechanistic experiments are needed to determine whether the differences observed in gut microbiota are the cause or consequences of severe RSV disease. BioMed Central 2020-06-01 /pmc/articles/PMC7268675/ /pubmed/32487019 http://dx.doi.org/10.1186/s12866-020-01816-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Harding, Jeffrey N.
Siefker, David
Vu, Luan
You, Dahui
DeVincenzo, John
Pierre, JF.
Cormier, Stephania A.
Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
title Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
title_full Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
title_fullStr Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
title_full_unstemmed Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
title_short Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
title_sort altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268675/
https://www.ncbi.nlm.nih.gov/pubmed/32487019
http://dx.doi.org/10.1186/s12866-020-01816-5
work_keys_str_mv AT hardingjeffreyn alteredgutmicrobiotaininfantsisassociatedwithrespiratorysyncytialvirusdiseaseseverity
AT siefkerdavid alteredgutmicrobiotaininfantsisassociatedwithrespiratorysyncytialvirusdiseaseseverity
AT vuluan alteredgutmicrobiotaininfantsisassociatedwithrespiratorysyncytialvirusdiseaseseverity
AT youdahui alteredgutmicrobiotaininfantsisassociatedwithrespiratorysyncytialvirusdiseaseseverity
AT devincenzojohn alteredgutmicrobiotaininfantsisassociatedwithrespiratorysyncytialvirusdiseaseseverity
AT pierrejf alteredgutmicrobiotaininfantsisassociatedwithrespiratorysyncytialvirusdiseaseseverity
AT cormierstephaniaa alteredgutmicrobiotaininfantsisassociatedwithrespiratorysyncytialvirusdiseaseseverity